Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
| Total reported revenue | 356M | 316M | 293M | 276M |
| Cost of revenue | 62M | 59M | 57M | 60M |
| Gross profit | 294M | 257M | 236M | 216M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 15M | 16M | 18M | 16M |
| Other operating expenses | — | — | — | 18M |
| Operating income | 279M | 241M | 218M | 200M |
| Non operating interest income | ||||
| Income | 1M | 13M | 4M | 10M |
| Expense | 82M | 99M | 96M | 107M |
| Other income expense | — | — | — | — |
| Pretax income | 403M | 455M | 244M | -880M |
| Tax provision | 93M | 92M | 34M | -146M |
| Net income | 310M | 363M | 209M | -734M |
| Basic EPS | 1.5 | 1.4 | 1.0 | -3.5 |
| Diluted EPS | 1.5 | 1.4 | 1.0 | -3.5 |
| Basic average shares | 858.7M | 2.8B | 2.2B | 2.2B |
| Diluted average shares | 858.7M | 2.8B | 2.2B | 2.2B |
| EBITDA | 428M | 337M | 232M | -384M |
| Net income from continuing op. | 279M | 242M | 218M | 200M |
| Minority interests | -5M | -5M | -2M | 18M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |